Wound dressings and systems with high-flow therapeutic gas sources for topical wound therapy and related methods
This disclosure includes wound dressings and systems with high-flow therapeutic gas sources for topical wound therapy and related methods. Some dressings, which are configured to be coupled to tissue to facilitate delivery of therapeutic gas to the tissue, comprise a manifold that defines a plurality of gas passageways, the manifold configured to allow communication of therapeutic gas to the tissue; and a gas-occlusive layer configured to be disposed over the manifold and coupled to the tissue such that an interior volume containing the manifold is defined between the gas-occlusive layer and the tissue and the gas-occlusive layer limits escape of therapeutic gas from the interior volume; wherein the gas-occlusive layer includes: a first opening configured to allow communication of therapeutic gas into the interior volume; and one or more second openings configured to allow communication of therapeutic gas out of the interior volume.
1. A dressing configured to be coupled to tissue to facilitate delivery of therapeutic gas to the tissue, the dressing comprising:
a manifold that defines a plurality of gas passageways, the manifold configured to allow communication of therapeutic gas to the tissue; and
a gas-occlusive layer configured to be disposed over the manifold and coupled to the tissue such that an interior volume containing the manifold is defined between the gas-occlusive layer and the tissue and the gas-occlusive layer limits escape of therapeutic gas from the interior volume;
wherein the gas-occlusive layer includes:
a first opening configured to allow communication of therapeutic gas into the interior volume; and
a plurality of second openings configured to allow communication of therapeutic gas out of the interior volume to an ambient environment, each of the plurality of second openings being spaced a uniform distance from the first opening.
2. The dressing of claim 1 , wherein each of the plurality of second openings includes a transverse dimension of approximately 1 to 10 millimeters (mm).
3. The dressing of claim 1 , wherein the gas-occlusive layer comprises a plurality of filters configured to allow communication of therapeutic gas out of the interior volume through the plurality of second openings and restrict communication of exudate out of the interior volume through the plurality of second openings.
4. The dressing of claim 3 , wherein at least one of the one or more filters includes a pore size of approximately 0.05 to 0.15 micrometers.
5. The dressing of claim 3 , wherein at least one of the one or more filters includes polytetrafluoroethylene or polyolefin.
6. The dressing of claim 1 , comprising a liquid control layer having a plurality of perforations, the liquid control layer configured to be disposed between the manifold and the tissue to restrict communication of exudate toward the tissue.
7. The dressing of claim 6 , wherein the liquid control layer includes an opening and at least a portion of the first opening of the gas-occlusive layer overlies at least a portion of the opening of the liquid control layer.
8. The dressing of claim 1 , wherein the manifold includes an opening and at least a portion of the first opening of the gas-occlusive layer overlies at least a portion of the opening of the manifold.
9. The dressing of claim 1 , comprising a port configured to extend through the first opening of the gas-occlusive layer to guide the communication of therapeutic gas into the interior volume.
10. The dressing of claim 9 , wherein: the manifold includes an opening and at least a portion of the first opening of the gas-occlusive layer overlies at least a portion of the opening of the manifold; and the port is configured to extend through the opening of the manifold and an opening of a liquid control layer to guide the communication of therapeutic gas into the interior volume.
11. The dressing of claim 1 , comprising a patient-interface layer configured to be disposed below the manifold and in contact with the tissue, the patient-interface layer defining a plurality of openings configured to allow communication of therapeutic gas and exudate through the patient-interface layer.
12. The dressing of claim 1 , comprising a sorbent layer having a sorbent material configured to be disposed above or below the manifold and to capture exudate.